Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-23T13:24:12.231Z Has data issue: false hasContentIssue false

The Podium

From the Lab to the Clinic: One Investigator's Journey

Published online by Cambridge University Press:  01 January 2021

Extract

Thank you very much, Ladies and Gentleman. I am very honored by the invitation to give a keynote address at this very informative, national meeting, before such a distinguished audience.

If you made a list of the hundreds of different activities that go on during the day in a major medical center and tried to rank order them in terms of degree of difficulty, or judgment required, or risk of error, or damage that can result from an error of omission or an error of commission, at the top of the list one might consider the teaching of a surgical resident at the operating table by a senior experienced surgeon, hours on end, often emotionally draining.

Type
Article
Copyright
Copyright © American Society of Law, Medicine and Ethics 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gardner, H. Csikszentmihalyi, M. Damon, W., Good Work: When Excellence and Ethics Meet (New York: Basic Books, 2001).Google Scholar
Interferon alpha is a chemical produced from the interaction of viruses with exposed animal cells. When subsequently used on uninfected cells, this chemical can induce protection from subsequent viral infection, acting much like a vaccine.Google Scholar
Hemangiomas are nonmalignant tumors comprised of newly formed blood vessels.Google Scholar
Brouty-Boye, D. Zetter, B.R., “Inhibition of Cell Motility by Interferon,” Science, 208 (1980): 516–18. Capillary endothelial cells are those cells which line the smallest blood vessels in the body.Google Scholar
White, C. et al. , “Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2a,” N. Engl. J. Med., 320 (1989): 11971200;.Google Scholar
Folkman, J., “Successful Treatment of an Angiogenic Disease,” N. Engl. J. Med., 320 (1989): 1211–12.Google Scholar
Ezekowitz, R.A. Mulliken, J.B. Folkman, J., “Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy,” N. Engl. J. Med., 326 (1992): 1456–63; Ezekowitz, R.A. Mulliken, J.B. Folkman, J., “Corrections,” N. Engl. J. Med., 330 (1994): 300;.CrossRefGoogle Scholar
Ezekowitz, A. Mulliken, J. Folkman, J., “Additional Corrections: Interferon for Hemangiomas of Infancy,” N. Eng. J. Med., 333 (1995): 595–96.Google Scholar
The subglottic region is an area of the airway or trachea below the voice box or larnyx.Google Scholar
Ohlms, L.A. et al. , “Interferon Alfa-2a Therapy for Airway Hemangiomas,” Annals of Otology, Rhinology and Laryngology, 103 (1994): 18.Google Scholar
Singh, R.K. et al. , “Interferons a and b Down-Regulate the Expression of Basic Fibroblast Growth Factor in Human Carcinomas,” Proceedings of the National Academy of Sciences, 92: 4562–66. Isaiah Fidler is a coauthor of this material.Google Scholar
Barlow, C.F. et al. , “Spastic Diplegia as a Complication of Interferon Alfa-2a Treatment of Hemangiomas of Infancy,” Journal of Pediatrics, 132 (1998): 527–30.CrossRefGoogle Scholar
Huang, S.A. et al. , “Severe Hypothyroidism Caused by Type 3 Iodothyronine Deiodinase in Infantile Hemangiomas,” N. Eng. J. Med., 343 (2000): 185–89.Google Scholar
Kaban, L.B. et al. , “Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible with Interferon Alfa-2a,” Pediatrics, 103 (1999): 1145–49.Google Scholar
Grealy, L., Autobiography of a Face (Boston: Houghton Mifflin, 1994).Google Scholar
Id. at book jacket cover.Google Scholar
Marler, J.J. et al. , “Successful Antiangiogenic Therapy of Giant Cell Angioblastoma with Interferon Alfa 2b: Report of 2 Cases,” Pediatrics, 109 (2002): 15.CrossRefGoogle Scholar
Mandible and maxilla both refer to bones of the jaw.Google Scholar
Enucleation surgery refers to removal of a tumor as an intact mass.Google Scholar
Kaban, L.B. et al. , “Antiangiogenic Therapy with Interferon Alpha for Giant Cells Lesions of the Jaws,” Journal of Oral and Maxillofacial Surgery, 60 (2002): 1103–111.Google Scholar
See Ezzel, C., “Starving Tumors of Their Lifeblood,” Scientific American, 279, no. 4 (1998): 3334.CrossRefGoogle Scholar